Outcomes of the first-in-human study with a recombinant botulinum toxin type E (rBoNT-E): Safety and pharmacodynamic profile of rBoNT-E compared with abobotulinumtoxinA (Dysport®). (December 2018)

Record Type:: Journal Article
Title:: Outcomes of the first-in-human study with a recombinant botulinum toxin type E (rBoNT-E): Safety and pharmacodynamic profile of rBoNT-E compared with abobotulinumtoxinA (Dysport®). (December 2018)
Main Title:: Outcomes of the first-in-human study with a recombinant botulinum toxin type E (rBoNT-E): Safety and pharmacodynamic profile of rBoNT-E compared with abobotulinumtoxinA (Dysport®)
Authors:: Pons, Laurent
Vilain, Claire
Picaut, Philippe
Abstract:
Is Part Of:: Toxicon. Volume 156(2018)Supplement 1
Journal:: Toxicon
Issue:: Volume 156(2018)Supplement 1
Issue Display:: Volume 156, Issue 1 (2018)
Year:: 2018
Volume:: 156
Issue:: 1
Issue Sort Value:: 2018-0156-0001-0000
Page Start:: S93
Page End:
Publication Date:: 2018-12
Subjects:: Toxins -- Periodicals
Venom -- Periodicals
615.9
Journal URLs:: http://www.sciencedirect.com/science/journal/00410101 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.toxicon.2018.11.224 ↗
Languages:: English
ISSNs:: 0041-0101
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 8873.050000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 9558.xml